Crossmark

Serum metabolites predict response to angiotensin II receptor blockers in patients with diabetes mellitus

Crossref DOI link: https://doi.org/10.1186/s12967-016-0960-3

Published Online: 2016-07-05

Published Print: 2016-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Pena, Michelle J.

Heinzel, Andreas

Rossing, Peter

Parving, Hans-Henrik

Dallmann, Guido

Rossing, Kasper

Andersen, Steen

Mayer, Bernd

Heerspink, Hiddo J. L.
Funding

Funding for this research was provided by:

Seventh Framework Programme (HEALTH–F2–2009–241544, EU-MASCARA (project no. 278249))

Novo Nordisk (NNF14SA0003)